Cargando…

Normal and Pathological NRF2 Signalling in the Central Nervous System

The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Heurtaux, Tony, Bouvier, David S., Benani, Alexandre, Helgueta Romero, Sergio, Frauenknecht, Katrin B. M., Mittelbronn, Michel, Sinkkonen, Lasse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394413/
https://www.ncbi.nlm.nih.gov/pubmed/35892629
http://dx.doi.org/10.3390/antiox11081426
_version_ 1784771484567207936
author Heurtaux, Tony
Bouvier, David S.
Benani, Alexandre
Helgueta Romero, Sergio
Frauenknecht, Katrin B. M.
Mittelbronn, Michel
Sinkkonen, Lasse
author_facet Heurtaux, Tony
Bouvier, David S.
Benani, Alexandre
Helgueta Romero, Sergio
Frauenknecht, Katrin B. M.
Mittelbronn, Michel
Sinkkonen, Lasse
author_sort Heurtaux, Tony
collection PubMed
description The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation, immunity, and differentiation have been attributed to this pleiotropic transcription factor that regulates hundreds of genes. After 40 years of in-depth research and key discoveries, NRF2 is now at the center of a vast regulatory network, revealing NRF2 signalling as increasingly complex. It is widely recognized that reactive oxygen species (ROS) play a key role in human physiological and pathological processes such as ageing, obesity, diabetes, cancer, and neurodegenerative diseases. The high oxygen consumption associated with high levels of free iron and oxidizable unsaturated lipids make the brain particularly vulnerable to oxidative stress. A good stability of NRF2 activity is thus crucial to maintain the redox balance and therefore brain homeostasis. In this review, we have gathered recent data about the contribution of the NRF2 pathway in the healthy brain as well as during metabolic diseases, cancer, ageing, and ageing-related neurodegenerative diseases. We also discuss promising therapeutic strategies and the need for better understanding of cell-type-specific functions of NRF2 in these different fields.
format Online
Article
Text
id pubmed-9394413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93944132022-08-23 Normal and Pathological NRF2 Signalling in the Central Nervous System Heurtaux, Tony Bouvier, David S. Benani, Alexandre Helgueta Romero, Sergio Frauenknecht, Katrin B. M. Mittelbronn, Michel Sinkkonen, Lasse Antioxidants (Basel) Review The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation, immunity, and differentiation have been attributed to this pleiotropic transcription factor that regulates hundreds of genes. After 40 years of in-depth research and key discoveries, NRF2 is now at the center of a vast regulatory network, revealing NRF2 signalling as increasingly complex. It is widely recognized that reactive oxygen species (ROS) play a key role in human physiological and pathological processes such as ageing, obesity, diabetes, cancer, and neurodegenerative diseases. The high oxygen consumption associated with high levels of free iron and oxidizable unsaturated lipids make the brain particularly vulnerable to oxidative stress. A good stability of NRF2 activity is thus crucial to maintain the redox balance and therefore brain homeostasis. In this review, we have gathered recent data about the contribution of the NRF2 pathway in the healthy brain as well as during metabolic diseases, cancer, ageing, and ageing-related neurodegenerative diseases. We also discuss promising therapeutic strategies and the need for better understanding of cell-type-specific functions of NRF2 in these different fields. MDPI 2022-07-22 /pmc/articles/PMC9394413/ /pubmed/35892629 http://dx.doi.org/10.3390/antiox11081426 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Heurtaux, Tony
Bouvier, David S.
Benani, Alexandre
Helgueta Romero, Sergio
Frauenknecht, Katrin B. M.
Mittelbronn, Michel
Sinkkonen, Lasse
Normal and Pathological NRF2 Signalling in the Central Nervous System
title Normal and Pathological NRF2 Signalling in the Central Nervous System
title_full Normal and Pathological NRF2 Signalling in the Central Nervous System
title_fullStr Normal and Pathological NRF2 Signalling in the Central Nervous System
title_full_unstemmed Normal and Pathological NRF2 Signalling in the Central Nervous System
title_short Normal and Pathological NRF2 Signalling in the Central Nervous System
title_sort normal and pathological nrf2 signalling in the central nervous system
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394413/
https://www.ncbi.nlm.nih.gov/pubmed/35892629
http://dx.doi.org/10.3390/antiox11081426
work_keys_str_mv AT heurtauxtony normalandpathologicalnrf2signallinginthecentralnervoussystem
AT bouvierdavids normalandpathologicalnrf2signallinginthecentralnervoussystem
AT benanialexandre normalandpathologicalnrf2signallinginthecentralnervoussystem
AT helguetaromerosergio normalandpathologicalnrf2signallinginthecentralnervoussystem
AT frauenknechtkatrinbm normalandpathologicalnrf2signallinginthecentralnervoussystem
AT mittelbronnmichel normalandpathologicalnrf2signallinginthecentralnervoussystem
AT sinkkonenlasse normalandpathologicalnrf2signallinginthecentralnervoussystem